These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 23897422)

  • 1. Blockade of the renin-angiotensin system in hypertensive patients with atherosclerotic renal artery stenosis.
    Jarraya F; Pruijm M; Wuerzner G; Burnier M
    Curr Hypertens Rep; 2013 Oct; 15(5):497-505. PubMed ID: 23897422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atherosclerotic renal artery stenosis: update on management strategies.
    Meier P
    Curr Opin Cardiol; 2011 Nov; 26(6):463-71. PubMed ID: 21799405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atherosclerotic renal artery stenosis: current status.
    Kwon SH; Lerman LO
    Adv Chronic Kidney Dis; 2015 May; 22(3):224-31. PubMed ID: 25908472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system.
    Scheen AJ
    Drugs; 2004; 64(22):2537-65. PubMed ID: 15516153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium channel blockers are associated with improved survival and lower cardiovascular mortality in patients with renovascular disease.
    Deshmukh H; Barker E; Anbarasan T; Levin D; Bell S; Witham MD; George J
    Cardiovasc Ther; 2018 Dec; 36(6):e12474. PubMed ID: 30372589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and risk factors for restenosis, and its impact on blood pressure control after percutaneous transluminal renal angioplasty in hypertensive patients with renal artery stenosis.
    Iwashima Y; Fukuda T; Yoshihara F; Kusunoki H; Kishida M; Hayashi S; Nakamura S; Kamide K; Horio T; Kawano Y
    J Hypertens; 2016 Jul; 34(7):1407-15. PubMed ID: 27065003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The changing etiology and therapeutic situation of atherosclerotic renal artery stenosis].
    Wang F; Wang M; Liu YC; Wang HY
    Zhonghua Yi Xue Za Zhi; 2005 Oct; 85(39):2762-6. PubMed ID: 16324317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of Hypertensive Patients with Renal Fibromuscular Dysplasia Compared with Patients with Concomitant Atherosclerotic Renal Artery Stenosis following Endovascular Therapy.
    Jenkins TL; Baker MG; Baheti AR; Sharma AM; Patrie JT; Angle JF; Matsumoto AH
    J Vasc Interv Radiol; 2015 May; 26(5):625-33; quiz 634. PubMed ID: 25921452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond blood pressure: evidence for cardiovascular, cerebrovascular, and renal protective effects of renin-angiotensin system blockers.
    Verdecchia P; Gentile G; Angeli F; Reboldi G
    Ther Adv Cardiovasc Dis; 2012 Apr; 6(2):81-91. PubMed ID: 22528743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure, antihypertensive medication, and atherosclerotic renal artery stenosis.
    Tullis MJ; Caps MT; Zierler RE; Bergelin RO; Polissar N; Cantwell-Gab K; Davidson RC; Strandness DE
    Am J Kidney Dis; 1999 Apr; 33(4):675-81. PubMed ID: 10196008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Balloon angioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis? A meta-analysis of randomized controlled trials.
    Nordmann AJ; Woo K; Parkes R; Logan AG
    Am J Med; 2003 Jan; 114(1):44-50. PubMed ID: 12557864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term safety and efficacy of renin-angiotensin blockade in atherosclerotic renal artery stenosis.
    Sofroniadou S; Kassimatis T; Srirajaskanthan R; Reidy J; Goldsmith D
    Int Urol Nephrol; 2012 Oct; 44(5):1451-9. PubMed ID: 22127407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting mechanisms of hypertensive vascular disease with dual calcium channel and renin-angiotensin system blockade.
    Weir MR
    J Hum Hypertens; 2007 Oct; 21(10):770-9. PubMed ID: 17597800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibitor usage in patients with incidental atherosclerotic renal artery stenosis.
    Yang JG; Hu D; Li T; Peng J; Yu H; Pang W; Wang C; Xiao J; Xu Y
    Hypertens Res; 2004 May; 27(5):339-44. PubMed ID: 15198481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Atherosclerotic nephropathy in renal artery stenosis--from randomized studies to individualized therapy].
    Oksa A; Dzúrik R; Demes M
    Vnitr Lek; 2003 Mar; 49(3):217-21. PubMed ID: 12728596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to manage hypertension with atherosclerotic renal artery stenosis?
    Ricco JB; Belmonte R; Illuminati G; Barral X; Schneider F; Chavent B
    J Cardiovasc Surg (Torino); 2017 Apr; 58(2):329-338. PubMed ID: 27998047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The future of renin inhibition].
    Uresin AY; Baran E
    Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual renin-angiotensin system inhibition for prevention of renal and cardiovascular events: do the latest trials challenge existing evidence?
    Mallat SG
    Cardiovasc Diabetol; 2013 Jul; 12():108. PubMed ID: 23866091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.